RSC
MDT icon

Red Spruce Capital’s Medtronic MDT Stock Holding History

Red Spruce Capital’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.02M Buy
25,799
+540
+2% +$43.6K 0.7% 52
2026
Q1 		$2.19M Buy
25,259
+1,266
+5% +$121K 0.9% 42
2025
Q4 		$2.3M Buy
23,993
+380
+2% +$36.9K 0.92% 40
2025
Q3 		$2.25M Sell
23,613
-94
-0.4% -$8.64K 0.92% 39
2025
Q2 		$2.07M Buy
23,707
+118
+0.5% +$10K 0.9% 37
2025
Q1 		$2.12M Buy
23,589
+1,037
+5% +$92.8K 1% 38
2024
Q4 		$1.8M Buy
22,552
+3,552
+19% +$307K 0.8% 44
2024
Q3 		$1.71M Sell
19,000
-226
-1% -$19K 0.78% 48
2024
Q2 		$1.51M Sell
19,226
-199
-1% -$16.3K 0.7% 51
2024
Q1 		$1.69M Buy
19,425
+1,473
+8% +$126K 0.79% 47
2023
Q4 		$1.48M Sell
17,952
-417
-2% -$31.8K 0.76% 47
2023
Q3 		$1.44M Sell
18,369
-692
-4% -$57.9K 0.82% 47
2023
Q2 		$1.68M Sell
19,061
-548
-3% -$47.2K 0.9% 41
2023
Q1 		$1.58M Buy
19,609
+999
+5% +$81.4K 0.93% 42
2022
Q4 		$1.45M Buy
18,610
+2,450
+15% +$199K 0.92% 41
2022
Q3 		$1.3M Buy
16,160
+286
+2% +$25.7K 0.92% 43
2022
Q2 		$1.43M Sell
15,874
-140
-0.9% -$14.2K 0.95% 39
2022
Q1 		$1.78M Buy
16,014
+272
+2% +$28.7K 1.01% 39
2021
Q4 		$1.63M Buy
15,742
+209
+1% +$24.2K 0.89% 44
2021
Q3 		$1.95M Buy
15,533
+51
+0.3% +$6.6K 1.14% 32
2021
Q2 		$1.92M Sell
15,482
-63
-0.4% -$7.91K 1.13% 35
2021
Q1 		$1.84M Hold
15,545
– – 1.17% 35
2020
Q4 		$1.82M Hold
15,545
– – 1.26% 28
2020
Q3 		$1.61M Sell
15,545
-541
-3% -$54.3K 1.31% 28
2020
Q2 		$1.48M Buy
16,086
+570
+4% +$54.7K 1.25% 30
2020
Q1 		$1.4M Sell
15,516
-287
-2% -$30.5K 1.45% 25
2019
Q4 		$1.79M Buy
+15,803
New +$1.73M 1.5% 25

Other funds holding MDT

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
GI
Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return
MAA
Matrix Asset Advisors White Plains, New York $1.23B AUM 26.4% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Red Spruce Capital's MDT Position: Q2 2026 in Review

Red Spruce Capital increased its Medtronic (MDT) stake by 2.1% in Q2 2026, buying an estimated $43.6K and bringing the position to 25,799 shares worth $2.02M. The position accounts for 0.7% of the portfolio, ranked #52.

Red Spruce Capital first reported a position in MDT in Q4 2019 and has held it in 27 quarters since. The position peaked at $2.3M in Q4 2025. 486 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Red Spruce Capital held 25,799 shares of Medtronic worth $2.02M as of Q2 2026.
  • Red Spruce Capital bought 540 Medtronic shares in Q2 2026, an estimated $43.6K.
  • Medtronic made up 0.7% of Red Spruce Capital's portfolio in Q2 2026, its #52 holding.
  • Red Spruce Capital first reported a position in Medtronic in Q4 2019 and has held it in 27 quarters since.
  • Red Spruce Capital's Medtronic position peaked at $2.3M in Q4 2025.
  • 486 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Red Spruce Capital's 13F filing for Q2 2026, filed 7 Jul 2026.